Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zyrtec vs Claritin in Children with SAR
NCT02932774Phase 4Completed
- Sponsor
- Johnson & Johnson
- Start
- Mar 2001
- Primary completion
- Jul 2001
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of cetirizine in seasonal allergic rhinitis (SAR) (3 arms), sponsored by Johnson & Johnson. Primary endpoint: Change from baseline to the Overall endpoint in the subject 24-hour reflective total symptom severity complex (TSSC) score at 2 weeks. Started Mar 2001; status: completed.
02
Drugs
cetirizine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT02932774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02932774.